beta-naphthamidine has been researched along with 1-aminoisoquinoline in 1 studies
Studies (beta-naphthamidine) | Trials (beta-naphthamidine) | Recent Studies (post-2010) (beta-naphthamidine) | Studies (1-aminoisoquinoline) | Trials (1-aminoisoquinoline) | Recent Studies (post-2010) (1-aminoisoquinoline) |
---|---|---|---|---|---|
8 | 0 | 0 | 26 | 0 | 14 |
Protein | Taxonomy | beta-naphthamidine (IC50) | 1-aminoisoquinoline (IC50) |
---|---|---|---|
Nitric oxide synthase, endothelial | Homo sapiens (human) | 1.4 | |
Nitric oxide synthase, brain | Homo sapiens (human) | 6.6 | |
Nitric oxide synthase, inducible | Homo sapiens (human) | 4.6 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Brown, SP; Muchmore, SW | 1 |
1 other study(ies) available for beta-naphthamidine and 1-aminoisoquinoline
Article | Year |
---|---|
Large-scale application of high-throughput molecular mechanics with Poisson-Boltzmann surface area for routine physics-based scoring of protein-ligand complexes.
Topics: Checkpoint Kinase 1; Chemistry, Pharmaceutical; Drug Discovery; Humans; Ligands; Models, Theoretical; Poisson Distribution; Protein Binding; Protein Kinases; Protein Tyrosine Phosphatase, Non-Receptor Type 1; Proteins; Quantitative Structure-Activity Relationship; Urokinase-Type Plasminogen Activator | 2009 |